Effect of Tablet Processing and Formulation Factors on Disintegration and Dissolution of Aceclofenac Tablets

DOI:

https://doi.org/10.37285/ijpsn.2010.3.4.9

Authors

  • C Mallikarjuna Setty
  • Radhika Muthadi
  • V.R.M Gupta
  • M.V.R. Reddy
  • Jithan A.V.

Abstract

 Aceclofenac, a non-steroidal anti-inflammatory drug, is used for posttraumatic pain and rheumatoid arthritis. The tablets were produced by simple wet granulation method. The post compressional parameters, hardness, friability, drug content of all the formulations were within the official limits. The disintegration time did not change with the type of diluents (mannitol, microcrystalline cellulose and dicalcium phosphate). However, it varied with the concentration of polyvinylpyrrolidone and microcrystalline cellulose. As the concentration of acacia was decreased, disintegration time decreased and hence, dissolution increased.  Incorporation of superdisintegrants improved the disintegration time as well as dissolution of the drug. As the granules size increased disintegration time decreased and increase in dissolution was noticed. It can be concluded that the selection of combination of variables and levels were important in the optimization of aceclofenac tablet formulation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Aceclofenac, wet granulation, binders, diluents, superdisintegrants, dissolution, disintegration

Downloads

Published

2011-02-28

How to Cite

1.
Setty CM, Muthadi R, Gupta V, Reddy M, A.V. J. Effect of Tablet Processing and Formulation Factors on Disintegration and Dissolution of Aceclofenac Tablets. Scopus Indexed [Internet]. 2011 Feb. 28 [cited 2024 May 10];3(4):1240-51. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/542

Issue

Section

Research Articles

References

Ansel HC, Popovich NG, Allen LV. Pharmaceutical dosage forms and drug delivery system. (8th ed), New Delhi.

Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. (3rd ed), Mumbai, 1987, pp. 296‐303, 316‐317.

Chang RK, Guo X, Burnside B, Couch R. Fast-dissolving tablets. Pharm .Techno. 24: 52-8 (2000).

Dobetti L. Fast-melting tablets: Developments and technologies. Pharm .Technol .Eur. 12:32-42 (2000).

Fiese EF, Hagen TA. Preformulation. In: Lachman L, Lieberma HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Mumbai, pp. 182‐184.

Hinz B, Auge D, Rau T, Rietbrock S, Brune K, Werner U. Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography. Biomed. Chromatogr. 17: 268-75 (2003).

Ho T, Hersey JA. Compactability of granules prepared by a novel method of granulation and their dissolution. J. Pharm. Pharmacol. 32: 160-6 (1980).

Indian Pharmacopoeia. (Vol. 2), New Delhi, 1996, pp.555‐6.

Kornasoff D, Frerick H, Bowdler J, Montull E. Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis. Clin. Rheumatol. 16 : 32-8 (1997).

Kristensen HG, Schaefer T. Drug. Dev .Ind. Pharm. 4&5: 803-872 (1987).

Kuchekar BS, Bhise SB, and Armugam V. Optimizing fast dissolving dosage form of diclofenac sodium by rapidly soluble disintegrating agents. Indian. J. Pharm. Educ .Res. 35 : 150 (2001).

Legrand E. Aceclofenac in the management of inflammatory pain. Exp Opin Pharmacother. 5: 1347 (2004).

Marrer S, Hausler H. Excipients, functionality impact on product quality and process performance. Pharm. Ind. 64 : 1083-1086 (2002).

Martin A, editor. Physical pharmacy. 4th ed. Philadelphia: Lippincott Willams and Wilkins; 1993, PP. 324-62.

Mizumoto T, Masuda Y, Yamamoto T, Yonemochi E, Tarada K. Formulation design of a novel fast disintegrating tablet. Int. J. Pharm. 306: 83-90 (2005).

Nystrom C, Westerberg M. Physicochemical aspects of drug release, II. The use of ordered mixtures for improving the dissolution rate of low solubility compounds. J.Pharm .Pharmacol. 38 :161-16 (1986).

Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur. J. Pharm. Sci. 15: 295-305 (2002).

Schreiner T, Ulrich F.Schaefer, Helmut Loth. Immediate drug release from solid oral dosage forms. J. Pharm. Sci. 94 : 120-33 (2005).

Selkirk AB, Gandertor D. The influence of wet and dry granulation methods on the pore structure of lactose tablets. J. Pharm. Pharmacol. 22 : 865-945 (1970).

Staniforth JN, Aulton ME. Powder flow In: Aulton’sPharmaceutics: the design and manufacturing of medicines. (3rded), Hungary, 2007, pp. 175‐79.

Sunada H, Bi Y, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm .Bull. 44 : 2121-7 (1996).

Sunada H, Bi YX, Yonezawa Y, Danjo K. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder.Technol. 122 : 188-98 (2002).

Takao M, Yoshinori M, Muneo F. Intrabuccally dissolving compressed mouldings and production process thereof. US patent 5 576 014; 1996.

The United State Pharmacopoeia 30/NF 25, Asian edition, the official compendia of standard United States Pharmacopoeial Convection Inc. Rockville.2007: 277.

Virley P, Yarwood R. Zydis. A novel fast dissolving dosage form. Manuf. Chem . 61: 22-9 (1990).

Yong CS, Oh YK, Lee KH, Park SM, Park YJ, Gil YS, et al. Trials of clear aceclofenac- loaded soft capsules with accelerated oral absorption in human subjects. Int. J. Pharm. 302: 78-83 (2005).